Sat, 27 Feb 2021

Breakthrough Therapies Industry


Wiseguyreports.Com Adds "Breakthrough Therapies: Market Dynamics and Investment Opportunities" To Its Research Database

The global market for breakthrough therapy designation drugs should reach $99.2 billion by 2022 from $48.8 billion in 2017 at a compound annual growth rate (CAGR) of 15.2%, from 2017 to 2022.

This report highlights the challenges and opportunities of developing breakthrough therapies, it compares and contrasts difference fast track drug development approaches (logistics, criteria, and implications) and the potential risk and rewards of gaining BTD. It analyzes BTD in different therapy areas (cardiovascular, central nervous systems and neurology, rare diseases, oncology and other diseases), leading companies, approved and pipeline products, pricing market access and product revenues. It reviews BTD successes and failures and discusses the different business strategies that companies have adopted in order to maximize the competitive advantage of BTD. It summarizes the current regulatory framework and the potential application of BTD in other regions of the world, and the potential to combine BTD with early access to medicine schemes to improve patient access to medicine to treat rare diseases and address areas of high unmet clinical need.

Request for Sample Report @

Report Includes:

- An overview of the global markets for breakthrough therapies, their dynamics, and investment opportunities - Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2022 - The challenges and opportunities of developing breakthrough therapies - A compare and contrast of different fast track drug development approaches (logistics, criteria and implications) and the potential risk and rewards of gaining break through designation - Analysis of the regulatory environment - Coverage of the market's dynamics, specifically growth drivers, restraints, and opportunities - Profiles of major players in the industry

Abbvie Inc. Acadia Pharmaceuticals Inc. Adaptimmune Therapeutics Plc Aduro Biotech Inc. Aimmune Therapeutics Inc. Alexion Pharmaceuticals Inc. Allergan Plc Amgen Inc. Anatara Lifesciences Limited Ariad Pharmaceuticals Inc. Astrazeneca Plc Avexis Inc. Boehringer Ingelheim Gmbh Celldex Therapeutics Inc. Clovis Oncology Inc. Daiichi Sankyo Company, Limited Dbv Technologies Eisai Co. Ltd. Eli Lilly And Company Exelixis Inc. F. Hoffmann-La Roche Ltd. Gilead Sciences Inc. Glaxosmithkline Plc Immunomedics Inc. Individor Plc Jazz Pharmaceuticals Juno Therapeutics Inc. Kite Pharma Inc. Merck & Co. Inc. Merck Kgaa Novartis Ag Pfizer Inc. Pharmacyclics Inc. Preliminary Clinical Evidence Progenics Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc. Rhythm Pharmaceuticals Inc. Syndax Pharmaceuticals Inc. Syneurx International Corporation Teva Pharmaceuticals Inc. Trevena Inc. Vertex Pharmaceuticals Inc. Vtesse Inc. Wellstat Therapeutics Corporation

Leave a Query @


Read Other Reports from our Database :

About the Author :

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Tags: , , , , , , , , , , , , , , , , , , , , ,

See Campaign: Information:Wiseguy Research Consultants


+6282580070Tags:, iCN Internal Distribution, Research Newswire, Englishimage

Contact Information:

Wiseguy Research Consultants



More Dallas News

Access More

Sign up for The Dallas News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!